DTT routinely performs High throughput transcriptomics (HTT) as part of 5 day in-vivo, and in-vitro screening using platforms such as S1500+, where the resulting data demands rigorous quality control and analysis. Contractor provides highly specialized tempo-seq data analysis for all HTT experiments at DTT.